[Prevention of undesirable effects in the use of catecholamines, phosphodiesterase inhibitors and beta-adrenoceptor antagonists during anesthesia].
Brandt
L
L
D000318:Adrenergic beta-Agonists / Q000009:adverse effects*; D000758:Anesthesia / Q000009:adverse effects*; D002395:Catecholamines / Q000009:adverse effects*; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*
D000318:Adrenergic beta-Agonists; D002395:Catecholamines; D010726:Phosphodiesterase Inhibitors
Vermeidung von Zwischenfällen bei der Anwendung von Katecholaminen, Phosphodiesterasehemmern und beta-Adrenozeptorantagonisten während der Anästhesie.